CONTENTS LETTER FROM LETTER FROM SUSTAINABILITY 2025 SUSTAINABILITY SUSTAINABILITY DRIVING SOCIAL HELPING PRESERVING NOEL WALLACE ANN TRACY HIGHLIGHTS SUSTAINABILITY MANAGEMENT GOVERNANCE IMPACT MILLIONS OF OUR STRATEGY HOMES ENVIRONMENT In 2021, we also joined the Chemical Footprint Project developed by Clean Production Action to Product Safety measure our footprint globally. The Chemical Footprint Project is aligned with the following United Nations Sustainable Development Goals: Good Health and Wellbeing, Clean Water and Sanitation The safety of our consumers and our people is our first and greatest concern. Our technical and Responsible Consumption and Production. teams conduct rigorous safety evaluations on all our products before we bring them to the marketplace and ensure our products comply with, and often exceed, all applicable regulatory Examples of more sustainable products include Palmolive products formulated with ingredients requirements wherever we do business. We work with regulatory agencies worldwide including that meet stringent safety criteria and performance standards and have earned EPA Safer Choice the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health certification. We offer these products in both fragrance and fragrance-free versions so that Organization (WHO) and Health Canada to ensure our products meet the highest standards of consumers can make their preferred choice. For more information, see Safer Choice program | safety—for both people and the environment. Palmolive® Promise. Safety Evaluation Process When we introduce new products or ingredients in our products, we apply the following rigorous evaluation process to ensure that the products or ingredients are safe, all applicable regulations are followed, and our consumers are informed about these ingredients. Assess: Before we use a new ingredient, we complete Monitor: It is our responsibility to continue to ensure a thorough safety assessment of the ingredient for the safety of our products once they are available both its intended use and foreseeable misuse. If the to purchase. Our pharmacovigilance team—made ingredient is found to be unsafe, we will not use it. up of physicians, pharmacists and nurses—gathers Develop: If the ingredient is determined safe, we information on adverse effects and quality complaints move forward with developing a product using the from health care professionals and via consumer new ingredient and evaluate the product’s efficacy phone calls, social media, mail, clinical trials, and potential adverse effects of its usage. If the market research and literature. After collecting and resulting product does not meet our standards, we go documenting that information, the team assesses back to the drawing board. and analyzes it to ensure that a product’s quality and safety is maintained throughout its lifecycle. Instruct: In the third stage, we ensure that proper warnings and use instructions are communicated on the label of the product. 2021 SUSTAINABILITY AND SOCIAL IMPACT REPORT PAGE 47